See also this year's filing and all EDGAR filings for this company.
PDF Report 0001810182_2023_ALX_ONCOLOGY_HOLDINGS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001810182, ALX ONCOLOGY HOLDINGS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 270,969,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,889,000 |
| 3 | remainder_Assets | 31,631,000 |
| 4 | LiabilitiesCurrent | 28,325,000 |
| 5 | LiabilitiesNoncurrent | 14,700,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,036,000 |
| 9 | ResearchAndDevelopmentExpense | 98,400,000 |
| 10 | remainder_Expenses | 64,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,018,000 |
| 13 | remainder_ComprehensiveNetIncome | -845,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 306,489,000 |
| 1 | Liabilities | 43,025,000 |
| 2 | Expenses | 127,500,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 263,464,000 |
| 5 | NetIncome | -123,482,000 |
| 6 | ComprehensiveNetIncome | -123,904,500 |
| 7 | BaseVar | 240,938,500 |
| 8 | EconomicCapitalRatio | 1.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
